$1.02 Billion is the total value of Logos Global Management LP's 53 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DSGN | New | DESIGN THERAPEUTICS INC | $81,702,000 | – | 2,732,501 | +100.0% | 7.97% | – |
| TIL | New | INSTIL BIO INC | $46,319,000 | – | 1,846,850 | +100.0% | 4.52% | – |
| EWTX | New | EDGEWISE THERAPEUTICS INC | $34,346,000 | – | 1,056,812 | +100.0% | 3.35% | – |
| BCYC | New | BICYCLE THERAPEUTICS PLCsponsored ads | $23,896,000 | – | 800,000 | +100.0% | 2.33% | – |
| CGEM | New | CULLINAN ONCOLOGY INC | $17,229,000 | – | 413,458 | +100.0% | 1.68% | – |
| CYTK | New | CYTOKINETICS INC | $16,282,000 | – | 700,000 | +100.0% | 1.59% | – |
| TPTX | New | TURNING POINT THERAPEUTICS I | $13,243,000 | – | 140,000 | +100.0% | 1.29% | – |
| IKNA | New | IKENA ONCOLOGY INC | $11,861,000 | – | 419,853 | +100.0% | 1.16% | – |
| VINC | New | VINCERX PHARMA INC | $9,264,000 | – | 480,000 | +100.0% | 0.90% | – |
| VRDN | New | VIRIDIAN THERAPEUTICS INC | $9,191,000 | – | 550,000 | +100.0% | 0.90% | – |
| ASLN | New | ASLAN PHARMACEUTICALS LTDads | $7,705,000 | – | 2,300,000 | +100.0% | 0.75% | – |
| ISEE | New | IVERIC BIO INC | $7,416,000 | – | 1,200,000 | +100.0% | 0.72% | – |
| KNSA | New | KINIKSA PHARMACEUTICALS LTD | $7,404,000 | – | 400,000 | +100.0% | 0.72% | – |
| LABP | New | LANDOS BIOPHARMA INC | $7,068,000 | – | 734,000 | +100.0% | 0.69% | – |
| HARP | New | HARPOON THERAPEUTICS INC | $6,276,000 | – | 300,000 | +100.0% | 0.61% | – |
| BOLT | New | BOLT BIOTHERAPEUTICS INC | $4,937,000 | – | 150,000 | +100.0% | 0.48% | – |
| KZR | New | KEZAR LIFE SCIENCES INC | $4,768,000 | – | 800,000 | +100.0% | 0.46% | – |
| VIRX | New | VIRACTA THERAPEUTICS INC | $4,348,000 | – | 470,000 | +100.0% | 0.42% | – |
| RACB | New | RESEARCH ALLIANCE CORP II | $3,075,000 | – | 300,000 | +100.0% | 0.30% | – |
| LHDX | New | LUCIRA HEALTH INC | $3,025,000 | – | 250,000 | +100.0% | 0.30% | – |
| FSII | New | FS DEVELOPMENT CORP II | $2,988,000 | – | 300,000 | +100.0% | 0.29% | – |
| DCPH | New | DECIPHERA PHARMACEUTICALS IN | $2,780,000 | – | 62,000 | +100.0% | 0.27% | – |
| CNTB | New | CONNECT BIOPHARMA HLDGS LTDads | $2,775,000 | – | 150,000 | +100.0% | 0.27% | – |
| ELDN | New | ELEDON PHARMACEUTICALS INC | $2,398,000 | – | 224,071 | +100.0% | 0.23% | – |
| ARYD | New | ARYA SCIENCES ACQU CORP IVcl a | $2,095,000 | – | 200,000 | +100.0% | 0.20% | – |
| NUVBWS | New | NUVATION BIO INC*w exp 07/07/202 | $178,000 | – | 66,666 | +100.0% | 0.02% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CYTOKINETICS INC | 14 | Q3 2023 | 12.6% |
| KARUNA THERAPEUTICS INC | 14 | Q3 2023 | 5.6% |
| ALX ONCOLOGY HLDGS INC | 13 | Q3 2023 | 23.3% |
| DYNE THERAPEUTICS INC | 13 | Q3 2023 | 4.9% |
| APELLIS PHARMACEUTICALS INC | 12 | Q3 2023 | 12.4% |
| OLEMA PHARMACEUTICALS INC | 12 | Q3 2023 | 15.4% |
| DESIGN THERAPEUTICS INC | 11 | Q3 2023 | 8.0% |
| NUVATION BIO INC | 11 | Q3 2023 | 0.0% |
| BICYCLE THERAPEUTICS PLC | 10 | Q2 2023 | 5.7% |
| IDEAYA BIOSCIENCES INC | 9 | Q3 2023 | 9.5% |
View Logos Global Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aeglea BioTherapeutics, Inc. | July 18, 2023 | 6,350,000 | 8.1% |
| BICYCLE THERAPEUTICS plc | February 14, 2023 | 1,435,000 | 4.8% |
| Dyne Therapeutics, Inc. | February 14, 2023 | 2,150,000 | 4.1% |
| Design Therapeutics, Inc. | March 31, 2022 | 2,797,501 | 5.0% |
| IDEAYA Biosciences, Inc. | March 18, 2022 | 2,650,000 | 6.9% |
| Aligos Therapeutics, Inc. | February 14, 2022 | ? | ? |
| Cogent Biosciences, Inc. | February 14, 2022 | 150,000 | 0.4% |
| Kezar Life Sciences, Inc. | February 14, 2022 | 1,450,000 | 3.0% |
| Nkarta, Inc. | February 14, 2022 | ? | ? |
| Viridian Therapeutics, Inc.\DE | February 14, 2022 | ? | ? |
View Logos Global Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-01 |
| SC 13G | 2024-02-22 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G | 2024-01-22 |
| SC 13G | 2024-01-22 |
| SC 13G | 2024-01-02 |
View Logos Global Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.